Clinical Guidelines

The NMSG do not write common Nordic Guidelines for the treatment of multiple myeloma, but NMSG members participate in the national committees writing the national guidelines in each country. We have one common guideline on the use of allogenic transplantation in multiple myeloma. Here you find this and all the national guidelines. 

NMSG
NMSG Recommendations for allogenic hematopoietic stem cell transplantation in multiple myeloma (2017) 

 

Denmark
The Danish Myeloma Study Group (DMSG) provides up to date evidence based guidelines for both clinical and laboratory hematologists on the diagnosis and treatment of hematological disease.
https://myeloma.hematology.dk/index.php/vejledninger-dmsg 

 

Sweden
The Swedish Myeloma Group provides national guidelines for the diagnosis and treatment of myeloma.

http://www.sfhem.se/riktlinjer 

 

Norway
The Norwegian Directorate of Health has published an action plan for myeloma. This is a part of a publication dealing with all kinds of blood diseases (in Norwegian):
https://www.helsedirektoratet.no/tema/kreft/maligne-blodsykdommer

Finland
The Finnish Hematology Association (SHY) provides national guidelines for diagnosis and treatment of myeloma. https://www.hematology.fi/fi/hoito-ohjeet/veritaudit/plasmasolutaudit/myelooma/hoito/kansalliset-hoitosuositukset-fmg

There are currently no published national guidelines for multiple myeloma in Iceland, Lithuania and Estonia. If you’re a doctor in these countries and have questions regarding the treatment of NMSG please contact nearest university hospital for current local guidelines.